These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 3527818)

  • 1. Role of muramyl peptides for the enhancement of synthetic vaccines.
    Chedid L; Audibert F; Jolivet M
    Dev Biol Stand; 1986; 63():133-40. PubMed ID: 3527818
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Use of muramyl dipeptides in models of synthetic vaccines].
    Audibert F
    Boll Ist Sieroter Milan; 1985; 64(2):95-102. PubMed ID: 3896261
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Production of anti-sporozoite antibodies in absence of response to carrier by coupling an MDP derivative to a malaria peptide-tetanus toxoid conjugate.
    Clough ER; Jolivet M; Audibert F; Barnwell JW; Schlesinger DH; Chedid L
    Biochem Biophys Res Commun; 1985 Aug; 131(1):70-6. PubMed ID: 4038309
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Biologically active antibodies elicited by a synthetic circumsporozoite peptide of Plasmodium knowlesi administered in saline with a muramyl dipeptide derivative.
    Clough ER; Audibert FM; Barnwell JW; Schlesinger DH; Arnon R; Chedid LA
    Infect Immun; 1985 Jun; 48(3):839-42. PubMed ID: 3997250
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synthetic immunomodulators and synthetic vaccines.
    Leclerc C; Vogel FR
    Crit Rev Ther Drug Carrier Syst; 1986; 2(4):353-406. PubMed ID: 3103928
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A potential anti-pregnancy vaccine built by conjugation of the beta-subunit of human chorionic gonadotropin to adjuvant-active muramyl peptide.
    Schutze MP; LeClerc C; Jolivet M; Deriaud E; Audibert F; Chang CC; Chedid L
    Am J Reprod Immunol Microbiol; 1987 Jul; 14(3):84-90. PubMed ID: 2445212
    [TBL] [Abstract][Full Text] [Related]  

  • 7. New developments in the field of synthetic muramyl peptides, especially as adjuvants for synthetic vaccines.
    Lederer E
    Drugs Exp Clin Res; 1986; 12(6-7):429-40. PubMed ID: 3527628
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of antibody avidity and titre elicited by peptide as a protein conjugate or as expressed in vaccinia.
    Lew AM; Anders RF; Edwards SJ; Langford CJ
    Immunology; 1988 Oct; 65(2):311-4. PubMed ID: 3056855
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Enhancement of the activity of hepatitis B virus vaccine by association with murabutide].
    Audibert F; Przewlocki G; Lefrancier P; Choay J; Chedid L
    C R Seances Acad Sci III; 1982 Nov; 295(10):611-4. PubMed ID: 6218866
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Production of antibodies recognizing a hepatitis B virus (HBV) surface antigen by administration of murabutide associated to a synthetic pre-S HBV peptide conjugated to a toxoid carrier.
    Przewlocki G; Audibert F; Jolivet M; Chedid L; Kent SB; Neurath AR
    Biochem Biophys Res Commun; 1986 Oct; 140(2):557-64. PubMed ID: 3778467
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficient genetically controlled formation of antibody to a synthetic antigen [poly(LTyr, LGlu)-poly(DLAla)- -poly(LLys)] covalently bound to a synthetic adjuvant (N-acetylmuramyl-L-alanyl-D-isoglutamine).
    Mozes E; Sela M; Chedid L
    Proc Natl Acad Sci U S A; 1980 Aug; 77(8):4933-7. PubMed ID: 6776530
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Modulation of carrier-induced epitopic suppression by Bordetella pertussis components and muramyl peptide.
    Vogel FR; Leclerc C; Schutze MP; Jolivet M; Audibert F; Klein TW; Chedid L
    Cell Immunol; 1987 Jun; 107(1):40-51. PubMed ID: 2438053
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Influence of a synthetic adjuvant (MDP) on qualitative and quantitative changes of serum globulins.
    Leclerc C; Audibert F; Chedid L
    Immunology; 1978 Dec; 35(6):963-70. PubMed ID: 738768
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The comparative selectivity of adjuvants for humoral and cell-mediated immunity. I. Effect on the antibody response to bovine serum albumin and sheep red blood cells of Freund's incomplete and complete adjuvants, alhydrogel, Corynebacterium parvum, Bordetella pertussis, muramyl dipeptide and saponin.
    Bomford R
    Clin Exp Immunol; 1980 Feb; 39(2):426-34. PubMed ID: 6248282
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Enhancement by murabutide of the immune response to natural and synthetic hepatitis B surface antigens.
    Audibert FM; Przewlocki G; Leclerc CD; Jolivet ME; Gras-Masse HS; Tartar AL; Chedid LA
    Infect Immun; 1984 Jul; 45(1):261-6. PubMed ID: 6735468
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Stimulation of the in vivo dinitrophenyl antibody response to the DNP conjugate of L-glutamic acid60-L-alanine30-L-Tyrosine10 (GAT) polymer by a synthetic adjuvant, muramyl dipeptide (MDP): target cells for adjuvant activity and isotypic pattern of MDP-stimulated response.
    Lowy I; Theze J; Chedid L
    J Immunol; 1980 Jan; 124(1):100-4. PubMed ID: 6965289
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reversal of T cell anergy in leprosy patients: in vitro presentation with Mycobacterium leprae antigens using murabutide and Trat peptide in liposomal delivery.
    Sridevi K; Khanna N; Chattree V; Pal PC; Haq W; Rao DN
    Int Immunopharmacol; 2003 Nov; 3(12):1589-600. PubMed ID: 14555284
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Stimulation of human endothelial cells by synthetic muramyl peptides: production of colony-stimulating activity (CSA).
    Galelli A; Dosne AM; Morin A; Dubor F; Chedid L
    Exp Hematol; 1985 Dec; 13(11):1157-63. PubMed ID: 3877645
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparative study of structurally related peptidoglycan monomer and muramyl dipeptide on humoral IgG immune response to ovalbumin in mouse.
    Habjanec L; Halassy B; Tomasić J
    Int Immunopharmacol; 2010 Jul; 10(7):751-9. PubMed ID: 20403461
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Enhancement of serum antibody production in mice by oral administration of lipophilic derivatives of muramyl peptides and bacterial lipopolysaccharides with bovine serum albumin.
    Ogawa T; Kotani S; Shimauchi H
    Methods Find Exp Clin Pharmacol; 1986 Feb; 8(2):117-25. PubMed ID: 3713372
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.